These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38957641)

  • 1. HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population.
    Pham NTU; Nguyen TV; Nguyen HT
    Dermatol Reports; 2024 Jun; 16(2):9854. PubMed ID: 38957641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the HLA-Cw6 genotype and zinc deficiency in psoriasis vulgaris patients in Indonesia.
    Sangian TY; Waspodo NN; Ilyas F; Djawad K; Seweng A; Tawali S
    Acta Dermatovenerol Alp Pannonica Adriat; 2023 Sep; 32(3):93-97. PubMed ID: 37749969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-Cw6 and psoriasis.
    Chen L; Tsai TF
    Br J Dermatol; 2018 Apr; 178(4):854-862. PubMed ID: 29072309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of childhood-onset psoriasis and prevalence of HLA-Cw6: a hospital-based study from India.
    Sathishkumar D; George R; Daniel D; Peter JV
    Postgrad Med J; 2015 Jun; 91(1076):309-14. PubMed ID: 25947201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features.
    Gudjónsson JE; Kárason A; Antonsdóttir AA; Rúnarsdóttir EH; Gulcher JR; Stefánsson K; Valdimarsson H
    J Invest Dermatol; 2002 Feb; 118(2):362-5. PubMed ID: 11841557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis.
    Queiro R; Torre JC; González S; López-Larrea C; Tinturé T; López-Lagunas I
    J Rheumatol; 2003 Mar; 30(3):505-7. PubMed ID: 12610809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab.
    Talamonti M; Botti E; Galluzzo M; Teoli M; Spallone G; Bavetta M; Chimenti S; Costanzo A
    Br J Dermatol; 2013 Aug; 169(2):458-63. PubMed ID: 23521149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations in IL6 and IL12B decreasing the risk for psoriasis.
    Boca AN; Talamonti M; Galluzzo M; Botti E; Vesa SC; Chimenti S; Buzoianu AD; Costanzo A
    Immunol Lett; 2013; 156(1-2):127-31. PubMed ID: 24140476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP).
    Enerbäck C; Martinsson T; Inerot A; Wahlström J; Enlund F; Yhr M; Swanbeck G
    Acta Derm Venereol; 1997 Jul; 77(4):273-6. PubMed ID: 9228217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis.
    Chiu HY; Wang TS; Chan CC; Cheng YP; Lin SJ; Tsai TF
    Br J Dermatol; 2014 Nov; 171(5):1181-8. PubMed ID: 24734995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene.
    Chang YT; Tsai SF; Lin MW; Liu HN; Lee DD; Shiao YM; Chin PJ; Wang WJ
    Exp Dermatol; 2003 Jun; 12(3):307-14. PubMed ID: 12823445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
    Costanzo A; Bianchi L; Flori ML; Malara G; Stingeni L; Bartezaghi M; Carraro L; Castellino G;
    Br J Dermatol; 2018 Nov; 179(5):1072-1080. PubMed ID: 29704432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Psoriasis due to combined effect of HLA-Cw6 and LCE3 risk alleles in Indian population.
    Chandra A; Lahiri A; Senapati S; Basu B; Ghosh S; Mukhopadhyay I; Behra A; Sarkar S; Chatterjee G; Chatterjee R
    Sci Rep; 2016 Apr; 6():24059. PubMed ID: 27048876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population.
    Jin Y; Zhang F; Yang S; Kong Y; Xiao F; Hou Y; Fan X; Zhang X
    J Dermatol Sci; 2008 Nov; 52(2):123-9. PubMed ID: 18585007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of HLA-Cw6 Positivity with Clinical Characteristics and Treatment Efficacy in Korean Patients with Psoriasis.
    Kim SM; Lee H; Lee ES
    Ann Dermatol; 2022 Aug; 34(4):253-260. PubMed ID: 35948327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population.
    Fan X; Yang S; Huang W; Wang ZM; Sun LD; Liang YH; Gao M; Ren YQ; Zhang KY; Du WH; Shen YJ; Liu JJ; Zhang XJ
    PLoS Genet; 2008 Mar; 4(3):e1000038. PubMed ID: 18369457
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Morelli M; Galluzzo M; Madonna S; Scarponi C; Scaglione GL; Galluccio T; Andreani M; Pallotta S; Girolomoni G; Bianchi L; Talamonti M; Albanesi C
    Expert Opin Biol Ther; 2021 Feb; 21(2):259-270. PubMed ID: 33297781
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of the HLA-Cw6 Allele and
    Queiro R; Braña I; Pardo E; Loredo M; Burger S; González Del Pozo P; Alvarez P; Fernández-Bretón E; Coto P; Coto E
    J Clin Med; 2024 Feb; 13(3):. PubMed ID: 38337541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis.
    Anzengruber F; Ghosh A; Maul JT; Drach M; Navarini AA
    Psoriasis (Auckl); 2017; 8():7-11. PubMed ID: 29721444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients.
    Enerbäck C; Nilsson S; Enlund F; Inerot A; Samuelsson L; Wahlström J; Swanbeck G; Martinsson T
    Arch Dermatol Res; 2000 Nov; 292(11):525-30. PubMed ID: 11194889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.